Evidence map›Paper›PMID 31773066›Full record

ReviewJournal of the anus, rectum and colon2018

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version).

Hideyuki Ishida, Tatsuro Yamaguchi, Kohji Tanakaya, Kiwamu Akagi, Yasuhiro Inoue, Kensuke Kumamoto, Hideki Shimodaira, Shigeki Sekine, Toshiaki Tanaka, Akiko Chino and 44 more

Abstract readReview
In one paragraph

Review in Journal of the anus, rectum and colon, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Two Cases of Thymic Cancer in Patients with Lynch Syndrome.Internal medicine (Tokyo, Japan) · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Recent advances in Lynch syndrome.Experimental hematology & oncology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors.

Hideyuki IshidaDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitma Medical University, Kawagoe, Japan.
Tatsuro YamaguchiDepartment of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Kohji TanakayaDepartment of Surgery, Iwakuni Clinical Center, Iwakuni, Japan.
Kiwamu AkagiDepartment of Cancer Prevention and Molecular Genetics, Saitama Prefectural Cancer Center, Saitama, Japan.
Yasuhiro InoueDepartment of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Tsu, Japan.
Kensuke KumamotoDepartment of Coloproctology, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu, Japan.
Hideki ShimodairaDepartment of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Shigeki SekineDivision of Pathology and Clinical Laboratories, National Cancer Center, Hospital, Tokyo, Japan.
Toshiaki TanakaDepartment of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Akiko ChinoDivision of Gastroenterology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Naohiro TomitaDepartment of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Takeshi NakajimaEndoscopy Division/Department of Genetic Medicine and Service, National Cancer Center Hospital, Tokyo, Japan.
Hirotoshi HasegawaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Takao HinoiDepartment of Surgery, Institute for Clinical Research, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan.
Akira HirasawaDepartment of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
Yasuyuki MiyakuraDepartment of Surgery Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Yoshie MurakamiDepartment of Oncology Nursing, Faculty of Nursing, Toho University, Tokyo, Japan.
Kei MuroDepartment of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Yoichi AjiokaDivision of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Yojiro HashiguchiDepartment of Surgery, Teikyo University, Tokyo, Japan.
Yoshinori ItoDepartment of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
Yutaka SaitoEndoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Tetsuya HamaguchiDivision of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Megumi IshiguroDepartment of Translational Oncology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Soichiro IshiharaDepartment of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yukihide KanemitsuColorectal Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Hiroshi KawanoDepartment of Gastroenterology, St. Mary's Hospital, Fukuoka, Japan.
Yusuke KinugasaDepartment of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Norihiro KokudoHepato-Pancreato-Biliary Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Keiko MurofushiRadiation Oncology Department, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Takako NakajimaDepartment of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
Shiro OkaGastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.
Yoshiharu SakaiDepartment of Surgery, Kyoto University, Kyoto, Japan.
Akihiko TsujiDepartment of Clinical Oncology, Faculty of Medicine, Kagawa University, Takamatsu, Japan.
Keisuke UeharaDivision of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hideki UenoDepartment of Surgery, National Defense Medical College, Saitama, Japan.
Kentaro YamazakiDivision of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Masahiro YoshidaDepartment of Hemodialysis and Surgery, Chemotherapy Research Institute, International University of Health and Welfare, Ichikawa, Japan.
Takayuki YoshinoDepartment of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
Narikazu BokuDivision of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Takahiro FujimoriDiagnostic Pathology Center, Shinko Hospital, Kobe, Japan.
Michio ItabashiDepartment of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Nobuo KoinumaDepartment of Health Administration and Policy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Takayuki MoritaDepartment of Surgery, Cancer Center, Aomori Prefectural Central Hospital, Aomori, Japan.
Genichi NishimuraDepartment of Surgery, Japanese Red Cross Kanazawa Hospital, Ishikawa, Japan.
Yuh SakataCEO, Misawa City Hospital, Misawa, Japan.
Yasuhiro ShimadaDivision of Clinical Oncology, Kochi Health Sciences Center, Kochi, Japan.
Keiichi TakahashiDepartment of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Shinji TanakaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Osamu TsurutaDivision of GI Endoscopy, Kurume University School of Medicine, Fukuoka, Japan.
Toshiharu YamaguchiDepartment of Gastroenterological Surgery, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Kenichi SugiharaKoujinkai Daiichi Hospital, Tokyo, Japan.
Toshiaki WatanabeDepartment of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Japanese Society for Cancer of the Colon and Rectum

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary colorectal cancer accounts for less than 5% of all colorectal cancer cases. Some of the unique characteristics that are commonly encountered in cases of hereditary colorectal cancer include early age at onset, synchronous/metachronous occurrence of the cancer, and association with multiple cancers in other organs, necessitating different management from sporadic colorectal cancer. While the diagnosis of familial adenomatous polyposis might be easy because usually 100 or more adenomas that develop in the colonic mucosa are in this condition, Lynch syndrome, which is the most commonly associated disease with hereditary colorectal cancer, is often missed in daily medical practice because of its relatively poorly defined clinical characteristics. In addition, the disease concept and diagnostic criteria for Lynch syndrome, which was once called hereditary non-polyposis colorectal cancer, have changed over time with continual research, thereby possibly creating confusion in clinical practice. Under these circumstances, the JSCCR Guideline Committee has developed the "JSCCR Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (HCRC)," to allow delivery of appropriate medical care in daily practice to patients with familial adenomatous polyposis, Lynch syndrome, or other related diseases. The JSCCR Guidelines 2016 for HCRC were prepared by consensus reached among members of the JSCCR Guideline Committee, based on a careful review of the evidence retrieved from literature searches, and considering the medical health insurance system and actual clinical practice settings in Japan. Herein, we present the English version of the JSCCR Guidelines 2016 for HCRC.

Indexed as

familial adenomatous polyposisguidelinehereditary colorectal cancerLynch syndrome

Identifiers

PMID31773066
PMCPMC6849642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.